EDITORIAL
Published on 04 Jan 2023
Editorial: Drug resistance in breast cancer – mechanisms and approaches to overcome chemoresistance
doi 10.3389/fonc.2022.1080684
- 1,910 views
- 2 citations
- Frontiers in Oncology
- Breast Cancer
- Research Topics
- Drug Resistance in Breast Cancer – Mechanisms and Approaches to Overcome Chemoresistance
Drug Resistance in Breast Cancer – Mechanisms and Approaches to Overcome Chemoresistance
21k
Total downloads
67k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 20 Apr 2022
Augmentation of Extracellular ATP Synergizes With Chemotherapy in Triple Negative Breast Cancer
doi 10.3389/fonc.2022.855032
- 2,019 views
- 4 citations
ORIGINAL RESEARCH
Published on 07 Apr 2022
Pyrotinib-Containing Neoadjuvant Therapy in Patients With HER2-Positive Breast Cancer: A Multicenter Retrospective Analysis
doi 10.3389/fonc.2022.855512
- 1,811 views
- 8 citations
REVIEW
Published on 21 Mar 2022
Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance
doi 10.3389/fonc.2022.856974
- 10,641 views
- 74 citations
CORRECTION
Published on 09 Mar 2022
Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1
doi 10.3389/fonc.2022.880458
- 828 views
ORIGINAL RESEARCH
Published on 18 Feb 2022
Chidamide Reverses Fluzoparib Resistance in Triple-Negative Breast Cancer Cells
doi 10.3389/fonc.2022.819714
- 2,839 views
- 6 citations
REVIEW
Published on 30 Nov 2021
Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer Therapies
doi 10.3389/fonc.2021.782766
- 12,137 views
- 54 citations
REVIEW
Published on 25 Oct 2021
MicroRNAs Role in Breast Cancer: Theranostic Application in Saudi Arabia
doi 10.3389/fonc.2021.717759
- 5,273 views
- 9 citations
ORIGINAL RESEARCH
Published on 21 Oct 2021
Which Clinicopathologic Parameters Suggest Primary Resistance to Palbociclib in Combination With Letrozole as the First-Line Treatment for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer?
doi 10.3389/fonc.2021.759150
- 2,710 views
- 9 citations
ORIGINAL RESEARCH
Published on 24 Sep 2021
High Expression of Complement Component C7 Indicates Poor Prognosis of Breast Cancer and Is Insensitive to Taxane-Anthracycline Chemotherapy
doi 10.3389/fonc.2021.724250
- 2,492 views
- 10 citations
REVIEW
Published on 13 Sep 2021
The Role of Non-Coding RNAs in Breast Cancer Drug Resistance
doi 10.3389/fonc.2021.702082
- 3,397 views
- 15 citations
ORIGINAL RESEARCH
Published on 26 Aug 2021
Cytotoxic Effects of Hellebrigenin and Arenobufagin Against Human Breast Cancer Cells
doi 10.3389/fonc.2021.711220
- 2,808 views
- 19 citations
